resiquimod has been researched along with dinoprostone in 5 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | resiquimod (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgeat, M; Borgeat, P; Hattermann, K; Leclerc, P; Picard, S; Pouliot, M | 1 |
| Holter, W; Lehner, M; Morhart, P; Stilper, A | 1 |
| Aarntzen, EH; Adema, GJ; Benitez-Ribas, D; Boullart, AC; de Boer, A; de Vries, IJ; Figdor, CG; Jacobs, JF; Kramer, M; Punt, CJ; Scharenborg, NM; Schreibelt, G; Schuurhuis, DH; van de Rakt, MW; Verdijk, P | 1 |
| Bosisio, D; Bugatti, M; Gianello, V; Salvi, V; Sozzani, S; Vaira, X; Vermi, W | 1 |
| Ahmed, AA; Attard Montalto, S; Brencicova, E; Diebold, SS; Evans, HG; Georgouli, M; Jagger, AL; Laios, A; Mehra, G; Raju-Kankipati, S; Spencer, J; Taams, LS | 1 |
5 other study(ies) available for resiquimod and dinoprostone
| Article | Year |
|---|---|
The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis.
Topics: Dinoprostone; Humans; Imidazoles; Inflammation Mediators; Leukotriene B4; Neutrophils; Platelet Activating Factor; RNA Viruses; Signal Transduction; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2007 |
Plasticity of dendritic cell function in response to prostaglandin E2 (PGE2) and interferon-gamma (IFN-gamma).
Topics: Cell Differentiation; Cell Movement; Colforsin; Cytokines; Dendritic Cells; Dinoprostone; Elasticity; Flow Cytometry; Humans; Imidazoles; Immunophenotyping; Interferon-gamma; Monocytes | 2008 |
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.
Topics: CD40 Ligand; Cell Movement; Cell Proliferation; Cells, Cultured; Dendritic Cells; Dinoprostone; Humans; Imidazoles; Interferon-gamma; Interleukin-12; Ligands; Monocytes; Poly I-C; Th1 Cells; Toll-Like Receptor 3; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors | 2008 |
TLR Signalling Pathways Diverge in Their Ability to Induce PGE2.
Topics: Blotting, Western; Cells, Cultured; Dendritic Cells; Dinoprostone; Electrophoresis, Polyacrylamide Gel; Humans; Imidazoles; Immunohistochemistry; Interleukin-8; Lipopolysaccharides; Real-Time Polymerase Chain Reaction; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2016 |
Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.
Topics: Antibodies, Neutralizing; Ascites; B7-2 Antigen; Cells, Cultured; Dendritic Cells; Dinoprostone; Female; Humans; Imidazoles; Interleukin-10; Interleukin-12; Interleukin-6; Lipopolysaccharides; Lymphocyte Activation; Monocytes; Ovarian Neoplasms; Poly I-C; T-Lymphocytes; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Up-Regulation | 2017 |